The landscape of cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumor growth has ended. A complex scenario where the molecular features of tumors seem to be the cornerstone of any therapy is now emerging. As there are some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanism underpinning their efficacy. Understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small molecules, antiangiogenics and viral therapy. Recently new biomarkers development and how it should rule and determine the future of therapeutic research in cancer.
EVLT combined with sclerosing foam is effective for treating varicose great saphenous veins.
Rheumatology is a dynamic field in the midst of a treatment revolution that is leading to dramatically improved outcomes for patients with RA.